151 related articles for article (PubMed ID: 38266303)
1. Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine.
Matono T; Suzuki S; Mori S; Ato M
Am J Trop Med Hyg; 2024 Mar; 110(3):483-486. PubMed ID: 38266303
[TBL] [Abstract][Full Text] [Related]
2. Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Tang ASO; Wong QY; Yeo ST; Ting IPL; Lee JTH; Fam TL; Chew LP; Chua HH; Muniandy P
Am J Case Rep; 2021 May; 22():e931655. PubMed ID: 34038399
[TBL] [Abstract][Full Text] [Related]
3. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
Mahapatra SB; Ramu G
Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
[TBL] [Abstract][Full Text] [Related]
4. Rare Variant of Leprosy Reaction (Lucio Phenomenon): A Case Series.
Rusyati LMM; Saputra H; Indah MS; Setyawati NK
Int J Mycobacteriol; 2024 Jan; 13(1):105-111. PubMed ID: 38771288
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy.
Ji B; Perani EG; Petinom C; N'Deli L; Grosset JH
Antimicrob Agents Chemother; 1994 Apr; 38(4):662-7. PubMed ID: 8031029
[TBL] [Abstract][Full Text] [Related]
6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial with clofazimine in leprosy.
Ganapati R; Dongre VV
Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
[TBL] [Abstract][Full Text] [Related]
8. Side effects of clofazimine therapy.
Ramu G; Iyer GG
Lepr India; 1976 Oct; 48(4 Suppl):722-31. PubMed ID: 1026810
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
Singh RP; Tiwari VD; Chattopadhyay SP
Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
[TBL] [Abstract][Full Text] [Related]
10. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
Chandorkar AG; Burte NP; Gade RK; Bulakh PM
Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
[TBL] [Abstract][Full Text] [Related]
11. Effect of three-year multidrug therapy in multibacillary leprosy patients.
Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
[TBL] [Abstract][Full Text] [Related]
12. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
13. Leprosy. Recognition and treatment.
Ramos-e-Silva M; Rebello PF
Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
[TBL] [Abstract][Full Text] [Related]
14. Combined clofazimine- and dapsone-resistant leprosy. A case report.
Kar HK; Bhatia VN; Harikrishnan S
Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
[TBL] [Abstract][Full Text] [Related]
15. Bacillaemia in leprosy and effect of multidrug therapy.
Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Ganguly NK
Lepr Rev; 1989 Sep; 60(3):197-201. PubMed ID: 2682105
[TBL] [Abstract][Full Text] [Related]
16. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
[TBL] [Abstract][Full Text] [Related]
17. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
Mendis S; Somasiri KG; Chularatna W
Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
[TBL] [Abstract][Full Text] [Related]
18. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978.
Browne SG; Harman DJ; Waudby H; McDougall AC
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886
[TBL] [Abstract][Full Text] [Related]
19. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
Queiroz RH; Melchior Júnior E; de Souza AM; Gouveia E; Barbosa JC; de Carvalho D
Pharm Acta Helv; 1997 Sep; 72(4):209-13. PubMed ID: 9372643
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of leprosy and response to treatment in Hong Kong.
Ho CK; Lo KK
Hong Kong Med J; 2006 Jun; 12(3):174-9. PubMed ID: 16760543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
